New Markers of Acute Kidney Injury: Giant Leaps and Baby Steps

摘要: Treatment of acute kidney injury has been hampered by the inability a creatinine-based diagnosis to allow clinicians intervene with timely treatments aimed at preventing further development disease point where renal replacement therapy is necessary or death occurs. Novel biomarkers have touted as tool which early detection can occur and, on that basis, novel be developed and delivered in process. Sufficient new discovered evaluated expect not one biomarker but panel applied according phase injury, baseline function comorbidities will for injury. Issues validation these remain, particularly heterogeneous populations critically ill patients. Nevertheless, we are rapidly moving towards an era proactive rather than traditional exclusion.